Proposed Combat Meth Compliance Fee Would Be Waived For Many Retailers
This article was originally published in The Tan Sheet
Executive Summary
Businesses already paying to support the Drug Enforcement Administration's Diversion Control Program would be exempt from paying an additional fee to certify they have trained employees on compliance with the Combat Meth Act, DEA says in a proposed rule
You may also be interested in...
FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule
Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
Distributions Of All Amounts Of PSE Would Be Regulated Under DEA Rule
The Drug Enforcement Administration continues developing enforcement tools to implement the Combat Meth Act with a Nov. 20 notice of proposed rulemaking to regulate the distribution of all amounts of pseudoephedrine and phenylpropanolamine
Combat Meth Act Compliance Can Trip Up Drug Retailers
Complying with the nationwide limit the Combat Meth Act set on sales of pseudoephedrine-containing OTCs is simpler than handling separate state or local laws, but retailers' responsibilities under the act have not been easily met, the head of a Montana pharmacy chain tells the Senate Finance Committee